Measurement and Analysis of Gas Composition in Digestive Tract
NCT ID: NCT05810805
Last Updated: 2023-04-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
460 participants
OBSERVATIONAL
2023-04-01
2024-03-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Methane and Hydrogen Breath Test for the Diagnosis of Small Intestinal Bacterial Overgrowth
NCT06483360
Clinical Characteristics of Small Intestinal Bacterial Overgrowth in Individuals with Abdominal Distention
NCT06285734
Assessing the Prevalence and Epidemiological Characteristics of Small Intestinal Bacterial Overgrowth (SIBO) in Patients With Autoimmune Gastritis(AIG) Through Hydrogen and Methane Breath Testing(HMBT).
NCT06946706
Combined Screening for Gastrointestinal Tumors
NCT06478030
Medical Consortium for Screening Upper Gastrointestinal Cancers With Magnetically Controlled Capsule Gastroscopy
NCT04032353
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
gas component of digestive tract
Analyze the differences in gas components in different segments of the digestive tract in patients with different diseases, and analyze the correlation between specific gases and digestive tract diseases and non-specific symptoms.
Imflammtory bowel disease group
gas component of digestive tract
Analyze the differences in gas components in different segments of the digestive tract in patients with different diseases, and analyze the correlation between specific gases and digestive tract diseases and non-specific symptoms.
Irritable bowel syndrome group
gas component of digestive tract
Analyze the differences in gas components in different segments of the digestive tract in patients with different diseases, and analyze the correlation between specific gases and digestive tract diseases and non-specific symptoms.
Colorectal neoplasms group
gas component of digestive tract
Analyze the differences in gas components in different segments of the digestive tract in patients with different diseases, and analyze the correlation between specific gases and digestive tract diseases and non-specific symptoms.
Helicobacter pylori infection group
gas component of digestive tract
Analyze the differences in gas components in different segments of the digestive tract in patients with different diseases, and analyze the correlation between specific gases and digestive tract diseases and non-specific symptoms.
functional dyspepia group
gas component of digestive tract
Analyze the differences in gas components in different segments of the digestive tract in patients with different diseases, and analyze the correlation between specific gases and digestive tract diseases and non-specific symptoms.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
gas component of digestive tract
Analyze the differences in gas components in different segments of the digestive tract in patients with different diseases, and analyze the correlation between specific gases and digestive tract diseases and non-specific symptoms.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients undergoing endoscopic examination
Exclusion Criteria
* Patients have history of gastrointestinal surgery
* Patients who failed to complete the endoscopic examination due to various reasons
* Patients Boston score of Bowel preparation≤ 6 points
* Patients who have medication history of probiotics, antibiotics, PPIs and prokinetic drugs in the last 4 weeks
* Patients who combined with thyroid disease and other diseases that affect gastrointestinal motility
* Patients who combined with other risk factors such as mental illness, alcoholism, and drug abuse
* Patients who unable or unwilling to provide informed consent
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xiuli Zuo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiuli Zuo
director of Qilu Hospital gastroenterology department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Qilu Hospital, Shandong University
Jinan, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023SDU-QILU-G001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.